AstraZeneca Pharma India Limited is leading a major push in AI-enabled lung cancer screening with a new partnership signed today with the Government of Telangana. The initiative will roll out AI-enabled lung cancer screening across 20 public...
Siemens Healthineers today announced the expansion of manufacturing footprint in India with the local production of the Artis one Edition X angiography system at company’s Bengaluru factory. The system will be manufactured alongside the...
Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its dapagliflozin tablets in 5 mg and 10 mg strengths. This approval marks another important step in the company’s effort to grow...
Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu inaugurated the Nuclear Medicine Block with PET scan at IGMC Shimla today, marking a major upgrade in the state’s public healthcare system.
India bioeconomy growth stands at USD 165.7 billion based on the latest government data, driven by biotech startups, policy support, and manufacturing push, strengthening its role in economic expansion.
The Punjab government is rapidly improving Healthcare Scheme Access through the Mukh Mantri Sehat Yojna, with ASHA workers taking the lead in enrolments across the state.
Granules India Limited has announced that its wholly owned subsidiary, Granules Life Sciences (GLS), has received a Voluntary Action Indicated (VAI) classification from the US Food and Drug Administration (USFDA) following an inspectio...
Wockhardt has moved closer to market approval after its antibiotic Zaynich received a positive nod from the Central Drugs Standard Control Organization, marking a breakthrough in antibiotic space.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its generic mental health drug — Paroxetine extended-release tablets, a medication commonly used to treat mental health conditions.
Alembic Pharmaceuticals Limited has secured USFDA approval for Paroxetine Extended-Release Tablets USP 12.5 mg, marking another step forward in its growing U.S. generics portfolio.
.jpg)
.jpg)
, CDSCO.jpg)